📰 Relations Dept News

Page 2 - Relations Dept News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Relations Dept. Real-time updates on events, politics, business and more.

Actuate Therapeutics Announces Poster Presentations at the 2022 AACR Annual Meeting

March 28, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United States New Orleans Rhode Island Brown University New Orleans Convention Center Kelseye Huntington

Source: apnews.com

Former Boeing Rotorcraft Director Joins Xeriant's Board of

March 9, 2022

Col. John “Bones” Parker (Ret.) brings expertise in rotorcraft and foreign military sales...

United States Boca Raton Boca Raton Airport Keith Duffy Alfreda Cunningham Company Board Of Advisors

Source: globenewswire.com

Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer

March 1, 2022

Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer - read this article along with other careers information, tips and advice on BioSpace

United States Anwaar Saeed Danielm Schmitt Razelle Kurzrock Actuate Therapeutics Inc Retifanlimab Incyte Corporation

Source: biospace.com

Actuate Therapeutics Announces Initiation of a Multicenter

February 7, 2022

Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical study initiated at Massachusetts General Hospital, Fred...

United States Dana Farber Cancer Institute Colind Weekes Andrew Rakeman Daniel Schmitt Johns Hopkins University